Cyclooxygenase 2 Inhibitors

A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients
Host-directed-therapy strategies are warranted to fight tuberculosis. Here we assess the safety and immunogenicity of adjunctive …
Synne Jenum, Kristian Tonby, Corina S. Rueegg, Morten Rühwald, Max P. Kristiansen, Peter Bang, Inge Christoffer Olsen, Kjersti Sellæg, Kjerstin Røstad, Tehmina Mustafa, Kjetil Taskén, Dag Kvale, Rasmus Mortensen, Anne Ma Dyrhol-Riise
Cite DOI
Consequences of handling missing data for treatment response in osteoarthritis: a simulation study
OBJECTIVE: To understand how handling of missing data influences the statistical power and bias of treatment effects in randomised …
I. C. Olsen, T. K. Kvien, T. Uhlig
Cite DOI